Arthritis is a common disease in the modern world. In the US alone, over fifty million adults live with this condition, most of which are women and those of age. In spite of this, few people have a proper understanding of the condition. The term Arthritis is a general term used to refer to all diseases of the joint and joint pains. There are more than 100 types of arthritis. Osteoarthritis is one such condition.
Osteoarthritis is characterized by the degeneration of the joint cartilage. The cartilage is a soft tissue within the joints. The breakdown of the cartilage leads to the joint bones rubbing against each other during movement. The results are swellings and pain at the joints. With time, the pain becomes intensified, and the joints become weaker. Though they are no cure available for this condition, many health providers such as the Osteo Relief Institute have specialized in relieving the pain and improving the quality of life for persons having this condition.
Previous, injury, family history, age and excess weight are some of the risk factors. Minimizing the effects of osteoarthritis requires the commitment of the patient. Osteo Relief Institute provides a comprehensive of self-management programs for osteoarthritis patients. The program combines medical treatments with exercise and daily routine.
The operation of the Institute
Osteo Relief Institute specializes in using cutting-edge FDA approved technologies. It provides the most advanced Osteoarthritis treatments. It handles both minor and chronic joint pains. Many who had tried other contemporary treatments without significant improvements have found help at the facility. Osteo Relief Institute has hugely invested in technologies that help pinpoint pain and improve accuracy in treatment.
Osteo Relief Institute is based in the Monmouth County, New Jersey. Its staff consists of board certified physical therapists and physicians. Its multidisciplinary clinics utilize several pain relief procedures for best results. The guiding principle at Osteo Relief Institute is the belief that all patients should first try all available alternatives before resorting to invasive and aggressive procedures. Additionally, the institute handles all patients as a part of its family making the services personal and comfortable.
Check out Osteo Relief Institute on LinkedIn | Facebook
Oncotarget, a peer-reviewed medical journal that has received numerous awards for its publications, has recently published information regarding the effectiveness of Vitamin C in the treatment of cancer. This information comes at a time where the medical community is desperate for cancer cures and effective cancer treatment. Chemotherapy, a treatment which is prescribed for more than 60 percent of cancer patients, is often not effective and generally leaves the patient’s body in a weakened state. According the the article published by Oncotarget, the use of Vitamin C and antibiotics has been shown to drastically reduce the potency, growth, and cellular makeup of existing cancer cells. The journal is peer reviewed and is published by Impact Journals.
Researchers involved in the laboratory trial stated that the Vitamin C and antibiotic combination works to effectively starve cancer cells. According to the Oncotarget study, researchers tested a cancer cell by feeding it antibiotics over the course of several weeks. Each week, the antibiotic treatment was followed by a dosage of Vitamin C. The Vitamin C protocol enabled the antibiotics to reduce the energy source that the cancer cell needed to thrive, replicate, and grow. With only a single energy source left (glucose), the cell was considerably weakened. The researchers then removed the remaining energy source to kill the cancer cell.
The publication of this study by Oncotarget has received welcomed feedback from the medical community. Researchers at the head of this trial have suggested that the antibiotic and Vitamin C cocktail could be used as a clinical trial or an addition to the treatment of cancer patients who have already seen a reduction in the growth of cancer cells. As the study is continued, the medical community has great hope that this protocol could help in the fight against cancer, which kills and debilitates millions of people around the globe on an annual basis. As a publication devoted to the furthering of non-traditional medical findings and research analysis, Oncotarget is also committed to the implementation of effective treatments in cancer protocols. The founder of the antibiotic and Vitamin C cancer protocol, Alexander Thompson, is a regular contributor to the Oncotarget Peer-Reviewed Medical Journal. Visit Oncotarget’s profile page at facebook.com